Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. Mediterr J Hematol Infect Dis [Internet]. 2019 Aug. 29 [cited 2026 May 1];11(1):e2019057. Available from: https://www.mjhid.org/mjhid/article/view/2019.057